Andreea Varga

3.2k total citations
60 papers, 470 citations indexed

About

Andreea Varga is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Andreea Varga has authored 60 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cardiology and Cardiovascular Medicine, 20 papers in Pulmonary and Respiratory Medicine and 20 papers in Oncology. Recurrent topics in Andreea Varga's work include Cancer Immunotherapy and Biomarkers (11 papers), Cardiovascular Function and Risk Factors (6 papers) and Blood Pressure and Hypertension Studies (6 papers). Andreea Varga is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Cardiovascular Function and Risk Factors (6 papers) and Blood Pressure and Hypertension Studies (6 papers). Andreea Varga collaborates with scholars based in Romania, France and United States. Andreea Varga's co-authors include Ioan Ţilea, Laura Mezquita, Jean‐Charles Soria, Alexandru Burlacu, David Planchard, Antoine Hollebecque, Septimiu Voidăzan, Capucine Baldini, Christophe Massard and Aurélien Marabelle and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Andreea Varga

50 papers receiving 464 citations

Peers

Countries citing papers authored by Andreea Varga

Since Specialization

Citations

This map shows the geographic impact of Andreea Varga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreea Varga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreea Varga more than expected).

Fields of papers citing papers by Andreea Varga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreea Varga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreea Varga. The network helps show where Andreea Varga may publish in the future.

Co-authorship network of co-authors of Andreea Varga

This figure shows the co-authorship network connecting the top 25 collaborators of Andreea Varga. A scholar is included among the top collaborators of Andreea Varga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreea Varga. Andreea Varga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	First‐in‐human phase 1 study of KHK2455 monotherapy and in combination with mogamulizumab in patients with advanced solid tumors	Cancer	Timothy A. Yap, Olivier Rixe et al.	2
2	Inflammation-Based Hematologic Indices as Prognostic Markers in Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension: A Hypothesis-Generating Registry Study	International Journal of Molecular Sciences	Andreea Varga, Ioan Ţilea et al.	0
3	Kidney Dysfunction, Hepatic Impairment, and Lipid Metabolism Abnormalities in Patients with Precapillary Pulmonary Hypertension	Diagnostics	Andreea Varga, Ioan Ţilea et al.	1
4	606O Initial results from a first-in-human study of the B7-H4-directed antibody-drug conjugate (ADC) AZD8205 (puxitatug samrotecan) in patients with advanced/metastatic solid tumors	Annals of Oncology	Funda Meric‐Bernstam, Yoichi Naito et al.	7
5	The Gender Gap in Aortic Dissection: A Prospective Analysis of Risk and Outcomes	The Journal of Critical Care Medicine	Klara Brînzaniuc, Ioan Ţilea et al.	2
6	FIP1L1–PDGFRα-Positive Loeffler Endocarditis—A Distinct Cause of Heart Failure in a Young Male: The Role of Multimodal Diagnostic Tools	Diagnostics	Andreea Varga, Ioan Ţilea et al.	1
7	Assessing the Effects of Medical Information on Parental Self-Medication Behaviors for Children’s Health: A Comparative Analysis	Medicina	Sergiu Chirilă, Andreea Varga et al.	1
8	1732MO Pembrolizumab and nintedanib for patients with advanced mesothelioma	Annals of Oncology	Capucine Baldini, Andreea Varga et al.	0
9	Short-Term Impact of Iron Deficiency in Different Subsets of Patients with Precapillary Pulmonary Hypertension from an Eastern European Pulmonary Hypertension Referral Center	International Journal of General Medicine	Ioan Ţilea, Manuela Rozalia Gabor et al.	4
10	Critical Care Management of Decompensated Right Heart Failure in Pulmonary Arterial Hypertension Patients – An Ongoing Approach	SHILAP Revista de lepidopterología	Ioan Ţilea, Andreea Varga et al.	6
11	Impact of aging on immune-related adverse events generated by anti–programmed death (ligand)PD-(L)1 therapies	European Journal of Cancer	Capucine Baldini, P. Martin Romano et al.	63
12	1930O Genomic alterations in solid tumours according to ESMO scale for clinical actionability of molecular targets (ESCAT)	Annals of Oncology	P. Martin Romano, Laura Mezquita et al.	5
13	Patterns of progression in patients treated for immuno-oncology antibodies combination	Cancer Immunology Immunotherapy	Alice Bernard‐Tessier, Capucine Baldini et al.	15
14	Chemotherapy beyond immune checkpoint inhibitors in patients with metastatic colorectal cancer	European Journal of Cancer	Patricia Martín-Romano, Samy Ammari et al.	15
15	Immunothérapie des glioblastomes	Bulletin du Cancer	Capucine Baldini, P. Martin Romano et al.	0
16	Organisational factors influencing early clinical trials enrollment: Gustave Roussy experience	European Journal of Cancer	Antoine Hollebecque, Andreea Varga et al.	11
17	Immunotherapy phase I trials in patients over 70 years with advanced solid tumours: The Gustave Roussy experience	Annals of Oncology	Eduardo Castañón, Valérie Dyevre et al.	1
18	Identification of new prognostic factors in phase I patients treated by immunotherapy	Annals of Oncology	Frédéric Bigot, Antoine Hollebecque et al.	2
19	Phase I/II trial of cabazitaxel plus abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel and abiraterone	Annals of Oncology	C. Massard, Joaquı́n Mateo et al.	20
20	Does atherosclerosis observed by routine scanning of the descending aorta during transesophageal echocardiography predict cardiovascular events?	Journal of the American College of Cardiology	Andreea Varga, Tamás Forster et al.	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefanie Senger Breakdown of academic impact, for papers by Josephina G. Kuiper Breakdown of academic impact, for papers by S. Seber Breakdown of academic impact, for papers by Barbara Iyen Breakdown of academic impact, for papers by Emily Robinson Breakdown of academic impact, for papers by Clara García-Carro Breakdown of academic impact, for papers by Jianhong Zhu Breakdown of academic impact, for papers by Stefania Mantarro